Skip to main content
. 2019 Sep 26;9:13909. doi: 10.1038/s41598-019-50458-9

Table 3.

Comparisons to normal values for left heart parameters12,31.

c.95 A > G carriers n = 17 c.95 A > G/RH n = 17 c.95 A > G/c.95 A > G n = 17

LVEDV/[mean]

n > 95% CI

1.05 (0.19)

2 (12%)

1.01 (0.21)

3 (18%)

1.12 (0.18)

5 (29%)

LVESV/[mean]

n > 95% CI

1.22 (0.31)

5 (29%)

1.17 (0.28)

2 (12%)

1.22 (0.22)

3 (18%)

LVSV/[mean]

n > 95% CI

0.97 (0.17)

1 (6%)

0.94 (0.21)

1 (6%)

1.06 (0.21)

3 (18%)

LVCI/[mean]

n > 95% CI

1.06 (0.17)

2 (12%)

1.04 (0.26)

1 (6%)

1.05 (0.22)

4 (24%)

LVEF/[mean]

n < 95% CI

0.92 (0.07)

4 (24%)

0.92 (0.08)

3 (18%)

0.94 (0.07)

3 (18%)

LV mass/[mean]

n > 95% CI

0.91 (0.17)

1 (6%)

0.87 (0.19)

0

1.03 (0.20)

1 (6%)

LV Peak Filling Rate/[mean]

n > 95% CI

1.07 (0.22)

0

1.00 (0.30)

0

1.23 (0.29)

0

Data are presented as n (%) or mean ± standard deviation. Comparisons include ratios to published means and 95% percentiles and numbers (%) above respective percentiles. CI, confidence intervals; [mean], published mean value; LV, left ventricle; LVEDV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume; LVSV, left ventricular stroke volume; LVEF, left ventricular ejection fraction; c.95 A > G carriers, heterozygote; c.95 A > G/RH, compound heterozygotes for c.95 A > G and the risk haplotype; c.95 A > G/c.95 A > G, homozygote. *P < 0.05. A p-value < 0.05 are considered significant.